1. Biochemistry and Chemical Biology
  2. Stem Cells and Regenerative Medicine
Download icon

SOX2 O-GlcNAcylation alters its protein-protein interactions and genomic occupancy to modulate gene expression in pluripotent cells

  1. Samuel A Myers
  2. Sailaja Peddada
  3. Nilanjana Chatterjee
  4. Tara Friedrich
  5. Kiichrio Tomoda
  6. Gregor Krings
  7. Sean Thomas
  8. Michael Broeker
  9. Jason Maynard
  10. Matthew Thomson
  11. Katherine Pollard
  12. Shinya Yamanaka
  13. Alma L Burlingame
  14. Barbara Panning  Is a corresponding author
  1. University of California, San Francisco, United States
  2. Gladstone Institute University of California, San Francisco, United States
Research Article
  • Cited 31
  • Views 3,138
  • Annotations
Cite this article as: eLife 2016;5:e10647 doi: 10.7554/eLife.10647

Abstract

The transcription factor SOX2 is central in establishing and maintaining pluripotency. The processes that modulate SOX2 activity to promote pluripotency are not well understood. Here, we show SOX2 is O-GlcNAc modified in its transactivation domain during reprogramming and in mouse embryonic stem cells (mESCs). Upon induction of differentiation SOX2 O-GlcNAcylation at serine 248 is decreased. Replacing wild type with an O-GlcNAc-deficient SOX2 (S248A) increases reprogramming efficiency. ESCs with O-GlcNAc-deficient SOX2 exhibit alterations in gene expression. This change correlates with altered protein-protein interactions and genomic occupancy of the O-GlcNAc-deficient SOX2 compared to wild type. In addition, SOX2 O-GlcNAcylation impairs the SOX2-PARP1 interaction, which has been shown to regulate ESC self-renewal. These findings show that SOX2 activity is modulated by O-GlcNAc modification, and provide a novel regulatory mechanism for this crucial pluripotency transcription factor.

Article and author information

Author details

  1. Samuel A Myers

    Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  2. Sailaja Peddada

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  3. Nilanjana Chatterjee

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  4. Tara Friedrich

    Gladstone Institute University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  5. Kiichrio Tomoda

    Gladstone Institute University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  6. Gregor Krings

    Department of Pathology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  7. Sean Thomas

    Gladstone Institute University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  8. Michael Broeker

    Center for Systems and Synthetic Biology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  9. Jason Maynard

    Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  10. Matthew Thomson

    Center for Systems and Synthetic Biology, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  11. Katherine Pollard

    Gladstone Institute University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  12. Shinya Yamanaka

    Gladstone Institute University of California, San Francisco, San Francisco, United States
    Competing interests
    Shinya Yamanaka, scientific advisor of iPS Academia Japan without salary.
  13. Alma L Burlingame

    Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  14. Barbara Panning

    Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    For correspondence
    barbara.panning@gmail.com
    Competing interests
    No competing interests declared.

Reviewing Editor

  1. Kathrin Plath, University of California, Los Angeles, United States

Publication history

  1. Received: August 8, 2015
  2. Accepted: March 5, 2016
  3. Accepted Manuscript published: March 7, 2016 (version 1)
  4. Accepted Manuscript updated: March 22, 2016 (version 2)
  5. Version of Record published: April 19, 2016 (version 3)

Copyright

© 2016, Myers et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,138
    Page views
  • 865
    Downloads
  • 31
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

  1. Further reading

Further reading

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics
    Krishna S Ghanta et al.
    Research Article

    Nuclease-directed genome editing is a powerful tool for investigating physiology and has great promise as a therapeutic approach to correct mutations that cause disease. In its most precise form, genome editing can use cellular homology-directed repair (HDR) pathways to insert information from an exogenously supplied DNA repair template (donor) directly into a targeted genomic location. Unfortunately, particularly for long insertions, toxicity and delivery considerations associated with repair template DNA can limit HDR efficacy. Here, we explore chemical modifications to both double-stranded and single-stranded DNA-repair templates. We describe 5′-terminal modifications, including in its simplest form the incorporation of triethylene glycol (TEG) moieties, that consistently increase the frequency of precision editing in the germlines of three animal models (Caenorhabditis elegans, zebrafish, mice) and in cultured human cells.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Paul Fischer et al.
    Research Article

    Enzymerhodopsins represent a recently discovered class of rhodopsins which includes histidine kinase rhodopsin, rhodopsin phosphodiesterases and rhodopsin guanylyl cyclases (RGCs). The regulatory influence of the rhodopsin domain on the enzyme activity is only partially understood and holds the key for a deeper understanding of intra-molecular signaling pathways. Here we present a UV-Vis and FTIR study about the light-induced dynamics of a RGC from the fungus Catenaria anguillulae, which provides insights into the catalytic process. After the spectroscopic characterization of the late rhodopsin photoproducts, we analyzed truncated variants and revealed the involvement of the cytosolic N-terminus in the structural rearrangements upon photo-activation of the protein. We tracked the catalytic reaction of RGC and the free GC domain independently by UV-light induced release of GTP from the photolabile NPE-GTP substrate. Our results show substrate binding to the dark-adapted RGC and GC alike and reveal differences between the constructs attributable to the regulatory influence of the rhodopsin on the conformation of the binding pocket. By monitoring the phosphate rearrangement during cGMP and pyrophosphate formation in light-activated RGC, we were able to confirm the M state as the active state of the protein. The described setup and experimental design enable real-time monitoring of substrate turnover in light-activated enzymes on a molecular scale, thus opening the pathway to a deeper understanding of enzyme activity and protein-protein interactions.